PMID 25157968 2014 Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
rs121913520 in
KIT gene and
Gastrointestinal Stromal Tumors
PMID 17259998 2007 These results suggest that different mutations, even at the same codon, in juxtamembrane domain of the c-kit gene show different inhibitory effects of imatinib, and that patients with GISTs or mast cell neoplasms possessing this Val559Ile mutation are resistant to imatinib therapy.